Loading company details...
Beta
Latest Form 4 (Oct 5, 2026): Cari Gallman (EVP, General Counsel): Exercise/Conversion of 4,559 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Cari Gallman, EVP, General Counsel | Exercise/Conversion | 4,559 | n/a |
| Oct 2, 2026 | Phyllis R. Yale | Grant/Award | 561 | $35.0K |
| Oct 2, 2026 | Theodore R. Samuels II | Grant/Award | 821 | $51.2K |
| Oct 2, 2026 | Derica W. Rice | Grant/Award | 621 | $38.8K |
| Oct 2, 2026 | Michael R. McMullen | Grant/Award | 561 | $35.0K |
| Oct 2, 2026 | Peter J. Arduini | Grant/Award | 561 | $35.0K |
| Sep 10, 2026 | Cristian Massacesi, EVP,Chief Med Offr,Head of Dev | Sale | 6,249 | $403.5K |
| Sep 3, 2026 | Bartie Wendy Short, EVP, Corporate Affairs | Exercise/Conversion | 1,236 | $82.7K |
| Aug 26, 2026 | Phil M. Holzer, SVP and Controller | Sale | 500 | $33.8K |
| Aug 4, 2026 | Cristian Massacesi, EVP,Chief Med Offr,Head of Dev | Exercise/Conversion | 51,172 | n/a |